Stochastic models of progression of cancer andtheir use in controlling cancer-related mortality
International Journal of Applied Mathematics and Computer Science (2003)
- Volume: 13, Issue: 3, page 279-287
- ISSN: 1641-876X
Access Full Article
topAbstract
topHow to cite
topReferences
top- Amos C.I., Wu X., Spitz M.R. (1999): Is there a genetic basis for lung cancer susceptibility?. - Recent Results Cancer Res., Vol. 151, pp. 3-12.
- Aoki T., Nakata H., Watanabe H., Nakamura K., Kasai T., Hashimoto H., Yasumoto K. and Kido M. (2000): Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. - Am. J. Roentgenol., Vol. 174, No. 3, pp. 763-768.
- Auer H., Warncke K., Nowak D., Koops F., Jaeger U., Kurzbauer R. and Ruediger H.W.(1999): Variations of p53 in cultured fibroblasts of patients with lung cancer who have a presumed genetic predisposition. - Am. J. Clin. Oncol., Vol. 22, No. 3, pp. 278-282.
- Bartoszynski R., Edler L., Hanin L., Kopp-Schneider A., Pavlova L., Tsodikov A., Zorin A. and Yakovlev A.Y. (2001): Modeling cancer detection: Tumor size as a source of information on unobservable stages of carcinogenesis. - Math. Biosci., Vol. 171, No. 2, pp. 113-142. Zbl0998.92021
- Bonneux L. (2002): Mammographic screening: No reliable supportingevidence? - Lancet, Vol. 360, No. 9334, pp. 720, (discussion).
- du Bois A. (2002): Mammographic screening: No reliable supporting evidence? - Lancet, Vol. 360, No. 9334, pp. 719-720, (discussion).
- Flehinger B.J. and Kimmel M. (1987): The natural history of lung cancer in a periodically screened population. - Biometrics, Vol. 43, No. 1, pp. 127-144. Zbl0616.62137
- Flehinger B.J., Kimmel M. and Melamed M.R. (1988): Natural history of adenocarcinoma-large cell carcinoma of the lung: Conclusions from screening programs in New York and Baltimore. - J. Natl. Cancer Inst., Vol. 80, No. 5, pp. 337-344.
- Flehinger B.J., Kimmel M. and Melamed M.R. (1992): The effect of surgical treatment on survival from early lung cancer. Implications for screening. - Chest, Vol. 101, No. 4, pp. 1013-1018.
- Flehinger B.J., Kimmel M., Polyak T. and Melamed M.R. (1993): Screening for lung cancer. The Mayo Lung Project revisited. - Cancer, Vol. 72, No. 5, pp. 1573-1580.
- Gates T.J. (2001): Screening for cancer: Evaluating the evidence. -Am. Fam. Physician, Vol. 63, No. 3, pp. 513-522.
- Goldman R., Enewold L., Pellizzari E., Beach J.B., Bowman E.D., Krishnan S.S.and Shields P.G. (2001): Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue. - Cancer Res., Vol. 61, No. 17, pp. 6367-6371.
- Gorlova O.Y., Kimmel M. and Henschke C. (2001): Modeling of long-term screening for lung carcinoma. - Cancer, Vol. 92, No. 6, pp. 1531-1540.
- Grann V.R. and Neugut A.I. (2003): Lung cancer screening at any price? - JAMA, Vol. 289, No. 3, pp. 357-358.
- Hasegawa M., Sone S., Takashima S., Li F., Yang Z.G., Maruyama Y. and Watanabe T. (2000): Growth rate of small lung cancers detected on mass CT screening. - Br.J. Radiol., Vol. 73, No. 876, pp. 1252-1259.
- Henschke C.I. and Yankelevitz D.F. (2000): CT screening for lung cancer. - Radiol. Clin. North Am., Vol. 38, No. 3, pp. 487-495.
- Henschke C.I., Yankelevitz D.F., Mirtcheva R., McGuinness G., McCauley D. and Miettinen O.S.; ELCAP Group. (2002): CT screening for lung cancer: Frequency and significance of part-solid and nonsolid nodules. - Am J Roentgenol., Vol. 178, No. 5, pp. 1053-1057.
- Hillerdal G., Henschke C. and Sone S. (2001): Screening for lung cancer-new possibilities with new methods. - Lakartidningen, Vol. 98, No. 17, pp. 2047-2051.
- Hsu T.C., Spitz M.R. and Schantz S.P. (1991): Mutagen sensitivity: A biologic marker of cancer cucseptibility. - Cancer Epidemiol. Biomarkers Prev., Vol. 1, No. 1, pp. 83-89.
- Kakinuma R., Ohmatsu H., Kaneko M., Eguchi K., Naruke T., Nagai K., Nishiwaki Y., Suzuki A. and Moriyama N. (1999): Detection failures in spiral CT screening for lung cancer: Analysis of CT findings. - Radiology, Vol. 212, No. 1, pp. 61-66.
- Kaneko M., Kusumoto M., Kobayashi T., Moriyama N., Naruke T., Ohmatsu H., Kakinuma R., Eguchi K., Nishiyama H. and Matsui E. (2000): Computed tomography screening for lung carcinoma in Japan. - Cancer, Vol. 89, Suppl 11, pp. 2485-2488.
- Kimmel M. and Flehinger B.J. (1991): Nonparametric estimation of the size-metastasis relationship in solid cancers. - Biometrics, Vol. 47, No. 3, pp. 987-1004. Zbl0734.62105
- Mahadevia P.J., Fleisher L.A., Frick K.D., Eng J., Goodman S.N. and Powe N.R. (2003): Lung cancer screening with helical computed tomography in older adult smokers: A decision and cost-effectiveness analysis. - JAMA, Vol. 289, No. 3, pp. 313-322.
- Marcus P.M. (2001): Lung cancer screening: An update. - J. Clin. Oncol., Vol. 19, Suppl. 1, pp. 83S-86S.
- Marcus P.M., Bergstralh E.J., Fagerstrom R.M., Williams D.E., Fontana R., Taylor W.F. and Prorok P.C. (2000): Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. - J. Natl. Cancer Inst., Vol. 92, No. 16, pp. 1308-1316.
- Miettinen O.S., Henschke C.I., Pasmantier M.W., Smith J.P., Libby D.M., Yankelevitz D.F. (2002): Mammographic screening: No reliable supporting evidence? - Lancet, Vol. 359, No. 9304, pp. 404-405.
- Olsen O. and Gotzsche P.C. (2001): Cochrane review on screening for breast cancer with mammography. - Lancet, Vol. 358, No. 9290, pp. 1340-1342.
- Patz E.F. Jr, Goodman P.C. and Bepler G. (2000): Screening for lung cancer. -N. Engl. J. Med., Vol. 343, pp. 1627-1633.
- Patz E.F. Jr, Black W.C. and Goodman P.C. (2001): CT screening for lung cancer: Not ready for routine practice. - Radiology, Vol. 221, No. 3, pp. 587-591.
- Pettersson F. (1991): Efficacy of cervical cancer screening. - Med. Oncol. Tumor Pharmacother., Vol. 8, No. 3, pp. 175-181.
- Smith R.A., Cokkinides V., von Eschenbach A.C., Levin B., Cohen C., Runowicz C.D., Sener S., Saslow D., Eyre H.J. (2002): American Cancer Society guidelines for the early detection of cancer. - CA Cancer J. Clin., Vol. 52, No. 1, pp. 8-22.
- Sobue T., Suzuki T., Matsuda M., Kuroishi T., Ikeda S. and Naruke T. (1992): Survival for clinical stage I lung cancer not surgically treated. Comparison between screen-detected and symptom-detected cases. - Cancer, Vol. 69, No. 3, pp. 685-692.
- Sone S., Li F., Yang Z.G., Honda T., Maruyama Y., Takashima S., Hasegawa M., Kawakami S., Kubo K., Haniuda M. and Yamanda T. (2001): Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. - Br. J. Cancer, Vol. 84, No. 1, pp. 25-32.
- Strauss G.M. (2000): Randomized population trials and screening for lung cancer: Breaking the cure barrier. - Cancer, Vol. 89, Suppl. 11, pp. 2399-2421.
- Strauss G.M. (2002): The Mayo Lung Cohort: A regression analysis focusing on lung cancer incidence and mortality. - J. Clin. Oncol., Vol. 20, No. 8, pp. 1973-1983.
- Strauss G.M, Gleason R.E. and Sugarbaker D.J. (1997): Screening for lung cancer. Another look; a different view. - Chest, Vol. 111, No. 3, pp. 754-768.
- Strauss G.M., Gleason R.E. and Sugarbaker D.J. (1993): Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening. - Chest, Vol. 103, No. 4 (Suppl.), pp. 337S-341S.
- Strong L.C. and Amos C.I. (1996): Inherited susceptibility, In: Cancer Epidemiology and Prevention (Schottenfeld D. and Fraumeni J.F. Jr, Eds.). - New York: Oxford University Press, pp. 559-583.
- Van Klaveren R.J., Habbema J.D., de Koning H.J., Oudkerk M., Damhuis R.A. and Hoogsteden H.C. (2001): Screening for lung cancer in the Netherlands: The role of spiral CT scan. - Ned Tijdschr Geneeskd, Vol. 145, No. 11, pp. 521-526.
- Wagner H. Jr and Ruckdeschel J.C. (1995): Screening, early detection, and early intervention strategies for lung cancer. - Cancer Contr., Vol 2, No. 6, pp. 493-502.
- Walter S.D. and Day N.E. (1983): Estimation of the duration of a pre-clinical disease state using screening data. - Am. J. Epidemiol., Vol. 118, No. 6, pp. 865-886.
- Walter S.D., Kubik A., Parkin D.M., Reissigova J., Adamec M. and Khlat M. (1992): The natural history of lung cancer estimated from the results of a randomized trial of screening. - Cancer Causes Contr., Vol. 3, No. 2, pp. 115-123.
- Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K. and Spitz M.R. (2000): Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. - J. Natl. Cancer Inst., Vol. 92, No. 21, pp. 1764-1772.
- Werth J. (2002): Mammographic screening: No reliable supporting evidence? - Lancet, Vol. 360, No. 9334, pp. 720-721 (discussion).
- Wu X., Gu J., Amos C.I., Jiang H., Hong W.K. and Spitz M.R. (1998): A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. - Cancer, Vol. 83, No. 6, pp. 1118-1127.
- Yamaguchi N., Tamura Y., Sobue T., Akiba S., Ohtaki M., Baba Y., Mizuno S.and Watanabe S. (1991): Evaluation of cancer prevention strategies by computerized simulation model: An approach to lung cancer. - Cancer Causes Contr., Vol. 2, No. 3, pp. 147-155.
- Yamaguchi N., Tamura Y., Sobue T., Akiba S., Ohtaki M., Baba Y., Mizuno S.and Watanabe S. (1994): Evaluation of cancer prevention strategies by computerized simulation model: Methodological issues. - Environ Health Perspect., Vol. 102, Suppl. 8, pp. 67-71.
- Yankelevitz D.F., Gupta R., Zhao B. and Henschke C.I. (1999): Small pulmonary nodules: Evaluation with repeat CT-preliminary experience. - Radiology, Vol. 212, No. 2, pp. 561-566.
- Yankelevitz D.F., Reeves A.P., Kostis W.J., Zhao B. and Henschke C.I. (2000): Small pulmonary nodules: Volumetrically determined growth rates based on CT evaluation. - Radiology, Vol. 217, No. 1, pp. 251-256.
- Yankelevitz D.F., Kostis W.J., Henschke C.I., Heelan R.T., Libby D.M., Pasmantier M.W. and Smith J.P. (2003): Overdiagnosis in chest radiographic screening for lung carcinoma: Frequency. - Cancer, Vol. 97, No. 5, pp. 1271-1275.